SAXENA NISHANT C (Chief Business Officer) received a stock award from CORBUS PHARMACEUTICALS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/22/2026ACC: 0001193125-26-237103
Officer· Chief Business Officer
Since May 2026
+250.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
250.60K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+58.30K
Price / share
—
Trade value
—
% of position
1665.7%
5/21/2026
3.50K→61.80K
Total
Net shares
+58.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 5/21/2026 | A · Award | +58.30K | — | — | 1665.7% | 3.50K | 61.80K |
| Total | +58.30K | $0.00 | ||||||
Derivative Transactions1
Stock options (right to buy)
Direct
Converts to
Common Stock
192.30K shares
Shares
+192.30K
Strike price
11.51
Held after
192.30K
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (right to buy) Direct | Common Stock192.30K shares | 5/21/2026 | A · Award | +192.30K | 11.51 | — | 192.30K |